GlassScriptPhysician profile
Deanna Wildes
NPI 1003199480
$1,131.21
in general payments reported to CMS, 2019-2025
10 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $311 · 2022: $436 · 2023: $192 · 2024: $92.00 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $768.91 | 2021-2023 | Xarelto |
| Organogenesis INC. | $140.96 | 2023-2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Boston Scientific Corporation | $58.70 | 2021-2022 | |
| Nxstage Medical, INC. | $54.63 | 2022 | |
| Smith+Nephew, INC. | $28.06 | 2024 | Grafix Pl, Stravix |
| Acera Surgical, INC. | $21.55 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.14 | 2025 | |
| Octapharma USA, INC. | $15.06 | 2025 | Fibryga |
| Lemaitre Vascular, INC. | $13.12 | 2022 | |
| Kerecis Limited | $12.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Wildes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.